Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Hilda T. Maibach et al.|Journal of Clinical Medicine|2020Cited by 32
Stimuli-responsive polymeric nanoplatform-mediating immune microenvironment remodeling and noggin silencing for osteogenic regenerationYongcan Li, Guocan Yu, Kai-Yuan Cheng et al.|Chemical Engineering Journal|2025Cited by 0